Baidu, Inc. (BIDU) Q4 2024 Earnings Call Transcript — Neutral
BIDU Seeking Alpha — February 18, 2025Baidu, Inc. (NASDAQ:BIDU ) Q4 2024 Earnings Conference Call February 18, 2025 7:30 AM ET Company Participants Juan Lin - Director, Investor Relations Robin Li - Co-Founder & Chief Executive Officer Junjie He - Interim CFO Conference Call Participants Alicia Yap - Citigroup Lincoln Kong - Goldman Sachs Alex Yao - JPMorgan Gary Yu - Morgan Stanley Wei Xiong - UBS Miranda Zhuang - Bank of America Securities Thomas Chong - Jefferies Operator Hello and thank you for standing by for Baidu's Fourth Quarter and Fiscal Year 2024 Earnings Conference Call. At this time, all participants are in listen-only mode.

FDA To Review Teva and Alvotech Drug That Could Compete With Regeneron's Eylea — Neutral
ALVO TEVA Investopedia — February 18, 2025Teva Pharmaceutical Industries (TEVA) and partner Alvotech (ALVO) said the Food and Drug Administration (FDA) agreed to review their AVTO6 treatment for eye disorders.

General Mills, Inc. (GIS) 2025 CAGNY Conference Transcript — Neutral
GIS Seeking Alpha — February 18, 2025General Mills, Inc. (NYSE:GIS ) 2025 CAGNY Conference February 18, 2025 8:00 AM ET Company Participants Jeffrey Harmening – Chairman and Chief Executive Officer Kofi Bruce – Chief Financial Officer Jeff Siemon – Vice President of Investor Relations and Corporate Finance Conference Call Participants Ken Goldman – JPMorgan Andrew Lazar – Barclays Jeffrey Harmening Thank you for that very kind introduction, Bonnie, and greetings to everyone here and listening on the webcast. It is an honor to kick off CAGNY Conference once again this year.

ANET Earnings After Close & Options Ahead of Report — Neutral
ANET Schwab Network — February 18, 2025Arista Networks (ANET) will report earnings after the closing bell. The company's stock tumbled with the majority of A.I.

UFP Industries Q4 Earnings Miss, Sales Surpass Estimates — Neutral
UFPI Zacks Investment Research — February 18, 2025UFPI's fourth-quarter 2024 results are hurt by softer demand and broad-based pricing pressures.

Expeditors International (EXPD) Reports Q4 Earnings: What Key Metrics Have to Say — Positive
EXPD Zacks Investment Research — February 18, 2025The headline numbers for Expeditors International (EXPD) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Shareholders that Lost Money on Newmont Corporation (NEM) Should Contact Levi & Korsinsky About Pending Class Action - NEM — Neutral
NEM Accesswire — February 18, 2025NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Newmont Corporation (NYSE:NEM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/newmont-corporation-lawsuit-submission-form?prid=130266&wire=1 or contact Joseph E. Levi, Esq.

Innovative Industrial Properties, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - IIPR — Neutral
IIPR Accesswire — February 18, 2025NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Innovative Industrial Properties, Inc. (NYSE:IIPR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/innovative-industrial-properties-inc-lawsuit-submission-form?prid=130267&wire=1 or contact Joseph E. Levi, Esq.

Shareholders that lost money on TELUS International (Cda) Inc. (TIXT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More — Neutral
TIXT Accesswire — February 18, 2025NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your TELUS International (Cda) Inc. (NYSE:TIXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/telus-international-lawsuit-submission-form?prid=130254&wire=1 or contact Joseph E. Levi, Esq.

Harmonic Inc. Being Investigated on Behalf of Harmonic Inc. Investors. Contact Levi & Korsinsky For Details — Neutral
HLIT Accesswire — February 18, 2025NEW YORK, NY / ACCESS Newswire / February 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Harmonic Inc. ("Harmonic Inc.") (NASDAQ:HLIT) concerning possible violations of federal securities laws. Harmonic reported its third quarter financial results on February 10, 2025.

Regeneron Pharmaceuticals, Inc. Class Action: Levi & Korsinsky Reminds Regeneron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - REGN — Neutral
REGN Accesswire — February 18, 2025NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=130247&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Notifies Shareholders of FMC Corporation (FMC) of a Class Action Lawsuit and an Upcoming Deadline — Neutral
FMC Accesswire — February 18, 2025NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your FMC Corporation (NYSE:FMC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fmc-corporation-lawsuit-submission-form?prid=130248&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 31, 2025 in Grocery Outlet Lawsuit - GO — Neutral
GO Accesswire — February 18, 2025NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Grocery Outlet Holding Corp. (NASDAQ:GO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/grocery-outlet-holding-corp-lawsuit-submission-form?prid=130262&wire=1 or contact Joseph E. Levi, Esq.

Class Action Filed Against Cardlytics, Inc. (CDLX) Seeking Recovery for Investors - Contact Levi & Korsinsky — Neutral
CDLX Accesswire — February 18, 2025NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cardlytics-lawsuit-submission-form?prid=130249&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Notifies GSK plc Investors of a Class Action Lawsuit and Upcoming Deadline - GSK — Neutral
GSK Accesswire — February 18, 2025NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gsk-lawsuit-submission-form?prid=130250&wire=1 or contact Joseph E. Levi, Esq.

Terra CO2 Announces US$82M in New Series B Funding to Accelerate Commercial Deployment of Sustainable Cement Technology — Neutral
EXP Business Wire — February 18, 2025GOLDEN, Colo.--(BUSINESS WIRE)--Terra CO2 (Terra), a leading US-based low-carbon building materials company, today announced it has signed Series B equity commitments for US$82M from a mix of financial and strategic investors. Co-led by Just Climate (established by Generation Investment Management), Eagle Materials (NYSE: EXP), and GenZero, the round has also attracted interest from several industrial partners with formal announcements forthcoming. Seed and Series A lead investor Breakthrough E.

STAAR Surgical Company Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - STAA — Neutral
STAA Accesswire — February 18, 2025NEW YORK, NY / ACCESS Newswire / February 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of STAAR Surgical Company ("STAAR Surgical Company") (NASDAQ:STAA) concerning possible violations of federal securities laws. Staar reported disappointing earnings for Q4 2024, blaming the results on weak demand in China and a drop in refractive procedures.

Class Action Filed Against Merck & Co., Inc. (MRK) - April 14, 2025 Deadline to Join - Contact Levi & Korsinsky — Neutral
MRK Accesswire — February 18, 2025NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/merck-co-inc-lawsuit-submission-form?prid=130252&wire=1 or contact Joseph E. Levi, Esq.

March 31, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against WBA — Neutral
WBA Accesswire — February 18, 2025NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Walgreens Boots Alliance, Inc. (NASDAQ:WBA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/walgreens-boots-alliance-inc-lawsuit-submission-form-2?prid=130253&wire=1 or contact Joseph E. Levi, Esq.

ATTENTION Manhattan Associates, Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights — Neutral
MANH Accesswire — February 18, 2025NEW YORK, NY / ACCESS Newswire / February 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Manhattan Associates, Inc. ("Manhattan Associates") (NASDAQ:MANH) concerning possible violations of federal securities laws. On January 28, 2025, after the market closed, Manhattan Associates published fourth quarter fiscal 2024 results and issued disappointing fiscal 2025 guidance that fell well short of expectations, suggesting a significant demand slowdown with implied 2.2% growth compared to 12.3% growth in FY2024.
